254 related articles for article (PubMed ID: 18937214)
1. Carbofuran poisoning detected by mass spectrometry of butyrylcholinesterase adduct in human serum.
Li H; Ricordel I; Tong L; Schopfer LM; Baud F; Mégarbane B; Maury E; Masson P; Lockridge O
J Appl Toxicol; 2009 Mar; 29(2):149-55. PubMed ID: 18937214
[TBL] [Abstract][Full Text] [Related]
2. Fast affinity purification coupled with mass spectrometry for identifying organophosphate labeled plasma butyrylcholinesterase.
Li H; Tong L; Schopfer LM; Masson P; Lockridge O
Chem Biol Interact; 2008 Sep; 175(1-3):68-72. PubMed ID: 18586231
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous quantification of soman and VX adducts to butyrylcholinesterase, their aged methylphosphonic acid adduct and butyrylcholinesterase in plasma using an off-column procainamide-gel separation method combined with UHPLC-MS/MS.
Liu CC; Huang GL; Xi HL; Liu SL; Liu JQ; Yu HL; Zhou SK; Liang LH; Yuan L
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Nov; 1036-1037():57-65. PubMed ID: 27718463
[TBL] [Abstract][Full Text] [Related]
4. Identification of butyrylcholinesterase adducts after inhibition with isomalathion using mass spectrometry: difference in mechanism between (1R)- and (1S)-stereoisomers.
Doorn JA; Schall M; Gage DA; Talley TT; Thompson CM; Richardson RJ
Toxicol Appl Pharmacol; 2001 Oct; 176(2):73-80. PubMed ID: 11601883
[TBL] [Abstract][Full Text] [Related]
5. A retrospective screening method for carbamate toxicant exposure based on butyrylcholinesterase adducts in human plasma with ultra-high performance liquid chromatography-tandem mass spectrometry.
Ren Z; Chen B; Liang D; Liu D; Lei W; Liu S
J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Jun; 1225():123775. PubMed ID: 37285767
[TBL] [Abstract][Full Text] [Related]
6. Molecular dissection of cholinesterase domains responsible for carbamate toxicity.
Loewenstein Y; Denarie M; Zakut H; Soreq H
Chem Biol Interact; 1993 Jun; 87(1-3):209-16. PubMed ID: 8343977
[TBL] [Abstract][Full Text] [Related]
7. Dichlorvos, chlorpyrifos oxon and Aldicarb adducts of butyrylcholinesterase, detected by mass spectrometry in human plasma following deliberate overdose.
Li B; Ricordel I; Schopfer LM; Baud F; Mégarbane B; Masson P; Lockridge O
J Appl Toxicol; 2010 Aug; 30(6):559-65. PubMed ID: 20809544
[TBL] [Abstract][Full Text] [Related]
8. Lamellipodin proline rich peptides associated with native plasma butyrylcholinesterase tetramers.
Li H; Schopfer LM; Masson P; Lockridge O
Biochem J; 2008 Apr; 411(2):425-32. PubMed ID: 18076380
[TBL] [Abstract][Full Text] [Related]
9. Detectable organophosphorus pesticide exposure in the blood of Nebraska and Iowa residents measured by mass spectrometry of butyrylcholinesterase adducts.
Jiang W; Lockridge O
Chem Biol Interact; 2013 Mar; 203(1):91-5. PubMed ID: 22989774
[TBL] [Abstract][Full Text] [Related]
10. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry of titanium oxide-enriched peptides for detection of aged organophosphorus adducts on human butyrylcholinesterase.
Jiang W; Murashko EA; Dubrovskii YA; Podolskaya EP; Babakov VN; Mikler J; Nachon F; Masson P; Schopfer LM; Lockridge O
Anal Biochem; 2013 Aug; 439(2):132-41. PubMed ID: 23624322
[TBL] [Abstract][Full Text] [Related]
11. Suitability of human butyrylcholinesterase as therapeutic marker and pseudo catalytic scavenger in organophosphate poisoning: a kinetic analysis.
Aurbek N; Thiermann H; Eyer F; Eyer P; Worek F
Toxicology; 2009 May; 259(3):133-9. PubMed ID: 19428953
[TBL] [Abstract][Full Text] [Related]
12. Mass spectrometry based proteomic approach for the screening of butyrylcholinesterase adduct formation with organophosphates.
Dubrovskii Y; Murashko E; Chuprina O; Beltyukov P; Radilov A; Solovyev N; Babakov V
Talanta; 2019 May; 197():374-382. PubMed ID: 30771950
[TBL] [Abstract][Full Text] [Related]
13. Polyethylene glycosylation prolongs the circulatory stability of recombinant human butyrylcholinesterase.
Chilukuri N; Parikh K; Sun W; Naik R; Tipparaju P; Doctor BP; Saxena A
Chem Biol Interact; 2005 Dec; 157-158():115-21. PubMed ID: 16253215
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of aging of mipafox-inhibited butyrylcholinesterase.
Kropp TJ; Richardson RJ
Chem Res Toxicol; 2007 Mar; 20(3):504-10. PubMed ID: 17323978
[TBL] [Abstract][Full Text] [Related]
15. Serum butyrylcholinesterase of non-human primate shows amine sensitive aryl acyl amidase and metallopeptidase activities and characteristics similar to those of the human serum enzyme.
Bhanumathy CD; Rao RV; Balasubramanian AS
Indian J Biochem Biophys; 1998 Jun; 35(3):148-56. PubMed ID: 9803663
[TBL] [Abstract][Full Text] [Related]
16. Butyrylcholinesterase accelerates cocaine metabolism: in vitro and in vivo effects in nonhuman primates and humans.
Carmona GN; Jufer RA; Goldberg SR; Gorelick DA; Greig NH; Yu QS; Cone EJ; Schindler CW
Drug Metab Dispos; 2000 Mar; 28(3):367-71. PubMed ID: 10681384
[TBL] [Abstract][Full Text] [Related]
17. Developing procedures for the large-scale purification of human serum butyrylcholinesterase.
Saxena A; Luo C; Doctor BP
Protein Expr Purif; 2008 Oct; 61(2):191-6. PubMed ID: 18602477
[TBL] [Abstract][Full Text] [Related]
18. Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma.
Li B; Sedlacek M; Manoharan I; Boopathy R; Duysen EG; Masson P; Lockridge O
Biochem Pharmacol; 2005 Nov; 70(11):1673-84. PubMed ID: 16213467
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous Time-concentration Analysis of Soman and VX Adducts to Butyrylcholinesterase and Albumin by LC-MS-MS.
Lee JY; Kim C; Lee YH
J Anal Toxicol; 2018 Jun; 42(5):293-299. PubMed ID: 29618078
[TBL] [Abstract][Full Text] [Related]
20. Detection of human butyrylcholinesterase-nerve gas adducts by liquid chromatography-mass spectrometric analysis after in gel chymotryptic digestion.
Tsuge K; Seto Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jun; 838(1):21-30. PubMed ID: 16569519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
